Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

LUTRONIC Showcases New Devices, Features Podium Presentations and a Symposium at AMWC
  • USA - English


News provided by

Lutronic Inc.

Mar 29, 2016, 03:00 ET

Share this article

Share toX

Share this article

Share toX


We focus much of our global efforts on physician education and partnerships with leaders in the aesthetic industry, AMWC demonstrates this commitment.

Post this

Seoul, Korea (PRWEB) March 29, 2016 -- Lutronic, a leading innovator of aesthetic laser and energy-based technology, announced today the release of two new devices, a multitude of podium presentations, and a symposium panel featuring world-renowned physicians at the upcoming Aesthetic & Anti-aging Medicine World Congress (AMWC) annual event in Monaco. “We are looking forward to the clinical presentations as well as our symposium,” said Dr. Glen Calderhead, Vice-president, Medicoscientific Affairs at Lutronic, “We focus much of our global efforts on physician education and partnerships with leaders in the aesthetic industry, AMWC demonstrates this commitment.” Register for the symposium at http://www.lutronic.com/amwc

Podium presentations include presentations on trending topics, such as Cosmetic Gynecology, LED Adjunctive Therapies, and Skin Tightening by Dr. Florian Heydecker and Dr. Glen Calderhead. While the Lutronic sponsored symposium will focus on a 2-year study follow up in Cosmetic Gynecology, Laser Delivered Cosmeceutical Skin Rejuvenation, the Latest in Anti-aging Fractional Technology and an Introduction to new products, such as the picosecond laser, Pico+4.

At the AMWC Exhibition, C5 Hall Diaghilev, Lutronic will be showcasing the launch of two new products to compliment their growing line of devices. Lutronic is the global leader Nd:YAG laser technology, and has now applied their expertise to the next generation of Nd:YAG devices; Pico+4 the premium picosecond laser.

Picosecond devices have only recently come onto the aesthetic marketplace and have not delivered results as expected, until now; the Pico+4 is breaking the barriers to improve outcomes of cases recalcitrant to treatment by other Q-switched lasers! “In developing this picosecond device, we wanted to ensure it would deliver improved fluence ranges, along with traditional gentle fluences, for expanded treatment options,” stated Haelyung Hwang, CEO of Lutronic. “Our focus was to deliver the performance needed while maintaining the safety and efficacy physicians have grown to expect from Lutronic devices.”

Picosecond pulse is one of many factors important when it comes to treating challenging or recalcitrant pigment cases; others include fluence, beam profile and wavelength. “The right combination of these is critical when developing a premium system with the multitude of options available to address each individually challenging case.” Stated Dr. BL Goo, Naeum Dermatology and Aesthetic Clinic, Seoul, Korea, “The Pico+4 has optimized the system for best performance; it has dual technology with 2 pulse options, 4 wavelengths, and the widest range of precise settings that I can choose, which enable me to more successfully treat difficult cases.”

Pico+4 is truly a premium device that not only offers best in class features but provides performance enhancements that optimize outcomes. Lutronic worked closely with leading physicians to develop the best variety of parameters, which provide ideal treatment fluences for improved outcomes, even on recalcitrant cases where other systems had no longer achieved results.

Lutronic will also be announcing the release of enCurve, an apoptosis-inducing radiofrequency system that targets adipocytes. This non-invasive device utilizes the ideal frequency, 27.12 MHz, to selectively heat adipocytes to the optimal temperature to cause denaturation of cells, leading to adipocyte apoptosis.

EnCurve offers best in class features for safety, comfort and convenience. “The enCurve applicator can be positioned over both the abdomen and flanks at the same time, providing a hands-free procedure. Because the EnCurve is never in direct contact with the skin, no heat is transferred directly to the epidermis, and a gentle breeze from the Air Mode keeps the skin over the target area perspiration free for additional safety.” stated Dr. NARK-KYUNG RHO, Leaders Aesthetic Laser & Cosmetic Surgery Center, Korea “EnCurve is a new generation of intelligent adipocyte-targeting systems to ensure great curves with maximum comfort for the patient, and minimum stress for the operator.”

The release of these two devices, podium speakers and sponsored symposium shows Lutronic’s continued commitment to deliver quality devices for use in Europe and around the globe.

About Pico+4

The Pico+4 platform offers both pico- and nanosecond modes with the performance of four wavelengths (1064, 532, 595 and 660 nm) to provide you with more options than ever before to address everything from standard treatments, to those hard to treat cases resistant to other Nd:YAG approaches. You can count on having the right power, pulse-width, wavelength and fluence you need for the outstanding outcomes your patients want, all from one premium platform.

Pico+4 is pending CE mark and it is not yet for sale in the US.

About enCurve
EnCurve utilizes a specialized frequency (27.12 MHz) to selectively target and heat adipocytes in order to cause denaturation of cells, leading to the programmed death of the targeted adipocytes. Employing smart features such as, Personalized Impedance Synchronization Application (PISA) and Air Mode, enCurve is the easy and comfortable way to reduce adipocytes through apoptosis-inducing radiofrequency.

About LUTRONIC

Lutronic, a leading innovator in advanced aesthetic and medical laser and related technology, was established over 15 years ago to bring intuitive, robust, versatile devices that are affordable and efficacious to the worldwide medical community. Committed to improving medicine, Lutronic partners with key opinion leaders to advance science and ensure the efficacy of its systems. All systems are versatile and offer multiple setting and treatment options for customized treatments, which optimize outcomes for a wide variety of conditions and treatments including melasma, tattoo removal, soft tissue incision, vascular lesions, hair removal, wrinkle reduction, rejuvenation, body/face contouring, chronic pain, healing and more.

With a focus on physician needs and patient outcomes, Lutronic dedicates time and funding toward the development of devices that offer features and improvements not found in today’s market. Devoting more than 20% of revenues to R&D, Lutronic holds more than 200 current and pending patents worldwide. With more than 270 employees worldwide, Lutronic has offices in the US, Korea, China, and Japan, a world-wide network of distributors, focused R&D centers in Korea, and is ever expanding.

Tracy Evleshin, Lutronic Inc., http://www.lutronic.com, +1 408-805-0096, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.